Our approach to bioresilience

Google DeepMind and Isomorphic Labs announced a joint approach to bioresilience aimed at preventing misuse of artificial intelligence models while enabling governments and scientists to use the technologies for outbreak preparedness. The companies said the effort focuses on prevention, detection and response. Over the past 12 months they have advanced more than 15 partnerships with government bodies, biosecurity organizations and research groups. For prevention, the companies follow a four-step safety process including threat modeling and monitoring and are adapting SynthID watermarking technology to help DNA synthesis providers screen for potentially risky AI-generated biological sequences. For detection, the AlphaEvolve agent optimizes algorithms for metagenomic sequencing analysis to help detect outbreaks faster and more cost-effectively. AlphaGenome and protein function annotation tools are also being explored to identify emerging threats. For response, trusted researchers are being granted access to Google DeepMind's latest AI systems to accelerate vaccine and countermeasure design. Isomorphic Labs has established a focused unit to rapidly deploy its AI-powered Drug Design Engine for medical countermeasures during novel outbreaks. The companies said the work aligns with their Frontier Safety Framework and broader management of chemical, biological, radiological and nuclear risks.